SWOG clinical trial number
SWOG-774/775
Hodgkin's Disease: Remission Induction with Mustargen, Oncovin, Prednisone and Procarbazine + Bleomycin (MOPP#4)
Closed
Phase
Published
Abbreviated Title
Hodgkin's Disease: Remission Induction with Mustargen, Oncovin, Prednisone and Procarbazine + Bleomycin (MOPP#4)
Activated
07/20/1971
Closed
08/23/1974
Publication Information Expand/Collapse
1985
Bleomycin in combination with MOPP in the management of advanced Hodgkin's disease: A Southwest Oncology Group experience. In: Bleomycin Chemotherapy, BI Sikic, M Rozencweig, SK Carter, eds.